Lyn Baranowski
Chief Executive Officer · Avalyn Pharma Inc.
Individual
- 2026
- May 1, 2026
- 1
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Lyn Baranowski files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- SR ONE CAPITAL MANAGEMENT, LLC - $10.00M in AVLN purchases and sales in the last 12 months
- Novo Holdings A/S - $10.00M in AVLN purchases and sales in the last 12 months
- Jill Carroll - $5.00M in AVLN purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Lyn Baranowski?
Lyn Baranowski is a corporate insider, tracked as Chief Executive Officer of Avalyn Pharma Inc. (AVLN). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Lyn Baranowski last file a Form 4?
The only primary Form 4 on record is dated 1 May 2026.